The optimal cut off value of KRAS testing for the selection of unresectable colorectal cancer patients more likely to benefit from treatment with anti-EGFR in the first line setting.
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Primary outcome(s): Progression-free survival (PFS)
创建时间：
2017-06-15
